LOOK WHO’S SELLING NTMD
The company’s chief medical officer exercised options to buy 60,000 shares last week at $1.16 and sold them for $21.94. In December, he sold 30,000 shares at $20.63 that he had acquired by exercising options at 8 cents a share. Meanwhile, the company itself has filed a ‘shelf registration’ to sell up to a quarter billion dollars worth of its stock and/or bonds – not an insignificant sum for a company this size.
Neither of these pieces of information is ‘dispositive,’ as they say – ‘finally determinative.’ But taken with the IMS prescription data suggesting that only a few hundred prescriptions for BiDil may have been written thus far (while expenses of more than $100 million for the year have been budgeted), one imagines that the chief medical officer, and the company, may be on to a good thing.
(A shelf registration doesn’t require a company to issue new securities, but puts it in a position to do so without regulatory delay.)
The stock closed last night at $19.90, for an overall market valuation, with just over 30 million shares outstanding, of $600 million.
Anything’s possible, but . . . don’t sell your puts.
BEFORE WE ATTACK IRAN . . .
The author argues that it’s a serious situation, but hardly a crisis.
Quote of the Day
The business of America is business.~Calvin Coolidge
Request email delivery
- Aug 21:
The Center Is Not Where You Think It Is — Make Your Bed
- Aug 18:
Frank Sinatra – 10 Minute Short
- Aug 17:
The Race Of Our Lives (No, Not That One)
- Aug 16:
- Aug 15:
200 Years In Four Remarkable Minutes
- Aug 14:
The Mob Connections
- Aug 13:
On Fred Trump And The Great Gatsby
- Aug 10:
- Aug 9:
Disowning The Best Little Boy In The World
- Aug 8:
Best Monopoly Games Ever
- Aug 21: